Re: Ortho Evra

From: l.glazerman@rcn.com
Tue Feb 28 08:44:22 2006


Sorry. Twice the relative risk of venous thromboembolism.

>---- Original message ----
>Date: Tue, 28 Feb 2006 09:15:10 -0600
>From: babycatchers@aol.com
>Subject: Re: Ortho Evra
>To: Multiple recipients of list OB-GYN-L <ob-gyn-

l@dns.obgyn.net> >
> Excuse my ignorance- could you state what 2X RR VTE
> stands for, please?
>
> -----Original Message-----
> From: Larry Glazerman <l.glazerman@rcn.com>
> To: Multiple recipients of list OB-GYN-L
> <ob-gyn-l@dns.obgyn.net>
> Sent: Mon, 27 Feb 2006 21:38:14 -0600
> Subject: RE: Ortho Evra
>
> I'm on Ortho's speaker's bureau. The bottom line is that

despite the new > info about a 60% higher average blood level with Evra than

with OCs, there > is NO data confirming an increased risk of any side effect.
>
> In conjunction with the FDA, Ortho has sponsored several

epidemiologic > studies. One is now in press, and, to summarize, shows no

difference in VTE > between Evra and a 35 mcg pill. A second study, equally well
done, not yet > published, apparently shows an increase from 1-2/10,000

VTE with OC to 2-4 > /10,000 with Evra. This is a RR of ~2, but an absolute risk of
1-2/10,000 > patients (very low, IMHO). Also, it should be noted that other
current > contraceptives have significant warnings in their package

inserts: >
> Seasonale - significantly higher bleeding rates
> Yasmin - ?problems with K+ due to spironolactone like effect
> NuvaRing - 2X RR VTE
>
> The fact remains that all of these hormonal contraceptives

are very safe, > probably none any safer or more dangerous significantly than
any other, and > ALL much safer than pregnancy!!!!!!
>
> Waiting for the flames :)
>
> Larry R. Glazerman, MD
>
> 610-402-0161
> l.glazerman@rcn.com
>
> -----Original Message-----
> From: ob-gyn-l@obgyn.net [mailto:ob-gyn-l@obgyn.net] On

Behalf Of Garry E. > Siegel, M.D.
> Sent: Monday, February 27, 2006 9:54 PM
> To: Multiple recipients of list OB-GYN-L
> Subject: Gyn: Ortho Evra
>
> The nice Ortho rep brought in a lunch today to talk about the
bad rap > Evra has gotten, yet it is (according to him) the most

prescribed > hormonal contraceptive in the US.
>
> Has anyone changed their habits regarding this since the

poop has hit > the fan, i.e. the FDA made Ortho change the labeling and

some brouhaha > about strokes? Has anyone seen the science on it?
>
> Garry
>
> --
> Garry E. Siegel, M.D.
> Private Practice
> Roswell, GA





use when must restrict search to only the ob-gyn-l forum...
Enter search keywords:
Returns per screen: Require all keywords:

Return to  OB-GYN-L Mail a New Message to the Forum: ob-gyn-l@obgyn.net
Forum Administrator: geffrey.klein@obgyn.net
Report Technical Problems: webmaster@obgyn.net
Last Updated: Fri May 2 04:43:46 2008

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.